Your browser doesn't support javascript.
loading
Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer.
Liu, Jing-Bo; Yan, Yong-Ji; Shi, Jing; Wu, Ya-Bing; Li, Yan-Feng; Dai, Lin-Feng; Ma, Xue-Tao.
Affiliation
  • Liu JB; Department of Urology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Medicine (Baltimore) ; 98(29): e16193, 2019 Jul.
Article in En | MEDLINE | ID: mdl-31335671
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatectomy / Prostatic Neoplasms / MicroRNAs Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Medicine (Baltimore) Year: 2019 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatectomy / Prostatic Neoplasms / MicroRNAs Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Medicine (Baltimore) Year: 2019 Document type: Article Affiliation country: China Country of publication: United States